TRANSITIONAL CELL CARCINOMA OF THE BLADDER

Clinical trials for TRANSITIONAL CELL CARCINOMA OF THE BLADDER explained in plain language.

Never miss a new study

Get alerted when new TRANSITIONAL CELL CARCINOMA OF THE BLADDER trials appear

Sign up with your email to follow new studies for TRANSITIONAL CELL CARCINOMA OF THE BLADDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Trial halted early: testing combo therapy for tough bladder cancers

Disease control Terminated

This study tested whether combining the chemotherapy drug docetaxel with the targeted drug lapatinib could help control advanced bladder cancer that had worsened after initial platinum-based chemotherapy. It aimed to see if this combination could slow cancer growth and was safe f…

Matched conditions: TRANSITIONAL CELL CARCINOMA OF THE BLADDER

Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control

Last updated Mar 10, 2026 12:53 UTC

TRANSITIONAL CELL CARCINOMA OF THE BLADDER

Get alerted when new TRANSITIONAL CELL CARCINOMA OF THE BLADDER trials appear

Trial halted early: testing combo therapy for tough bladder cancers